EPB41L4A and non-small cell lung carcinoma: EPB41L4A-AS1 was a repressor of the Warburg effect and played an important role in the metabolic reprogramming of cancer (Liao et al., 2019), and EPB41L4A-AS1 has been identified as a potential biomarker in non-small cell lung cancer (Wang et al., 2020).